Dialysis Prescription: Determinants and relationship with intradialytic complications and the dialysis dose. A prospective study.

Peter Uduagbamen
Babcock University/Babcock University Teaching Hospital, Ilishan-Remo, Nigeria
Prof | Bio
University College Hospital, Ibadan, Nigeria
  • Articles
  • Submited: October 13, 2021
  • Published: January 2, 2023


Introduction: Dialysis still remains the most common modality for the treatment of end stage kidney disease and it could be maneuvered to augment its dose, minimize complications and improve outcome. Dialysis prescription is a brief of how dialysis is to be given and involves adjustments in patients’ characteristics, disease or dialytic procedure. This study aimed to assess the determinants of the prescribed dialysis and its relationship with intradialytic complications and the dialysis dose.

Methods: A prospective study in which 1248 sessions for 232 consented participants with end stage kidney disease on maintenance hemodialysis were studied from 2017-2020. Biodata was taken, participants were examined and blood samples were taken to determine electrolytes, urea/creatinine and hematocrit. Pearson’s correlation was used to determine the strength of association between dialysis dose and some variables.

Results: Determinants of the prescribed dose were dialysis frequency (P<0.001), and predialysis systolic blood pressure (P<0.001) and packed cell volume (P<0.001). Dialysis sessions without significant intradialytic blood pressure changes were most likely to be completed, as sessions with intra-dialysis hypotension were most likely to be terminated. Participants dialyzed with high flux dialyzers, via an arterovenous fistula, higher blood flow and ultrafiltration rates had higher dialysis doses (P<0.001 in all instances).

Conclusion:  Higher dialysis doses were achieved with higher blood flow and ultrafiltration rates. Intradialytic hypotension was common with dialysis termination, higher blood flow and ultrafiltration rates. Intradialytic hypertension was common with low flux dialyzers. An optimized dialysis prescription is needed to deliver an adequate dialysis dose and minimize complications.




Download data is not yet available.


  1. Arije A, Kadiri S, Akinkugbe OO. The viability of haemodialysis as a treatment option for renal failure in a developing economy. Afr J Med med Sci 2000; 29: 311–314
  2. Agaba EI, Lopez A, Ma I, Martinez R, Tzamaloukas RA, Vanderjagt DJ. Chronic hemodialysis in a Nigerian teaching hospital: practice and costs. Int J Artif Organs 2003; 26(11): 991-5.
  3. Amini M, Aghighi M, Masoudkabir F, Zamyadi M, Norouzi S, Rajolani H et al. Hemodialysis adequacy and Treatment in Iranian Patients. A National Multicenter study. Iran J Kidney Dis 2011; 5(2): 103-9
  4. Rafik H, Aatif T, El Kabbaj D. The impact of blood flow rate on dialysis dose and phosphate removal in hemodialysis patients Saudi J Kidney Dis Trans 2018; 29(4): 872-878
  5. Brimble SK, Treleaven DJ, Onge JS, Carlisle. Onge J, Carhiale E.J. Risk factors for increased viability in dialysis delivery in hemodialysed patients. Nephrol Dial Transplant 2013; 18(10): 2112-17
  6. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012; 60(5): 850-886
  7. Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LYC et al. Prescription of Twice-Weekly Hemodialysis in the USA. Am J Nephrol 1999; 19: 625-633 doi.org/10.1159/000013533
  8. Geddes CC, Traynor J, Walbaum D, Fox JG, Mactier RA. A new method of post-dialysis blood urea sampling: the `stop dialysate flow' method Nephrol Dial Trans, 2000; 15(4): 517–523
  9. . Daugirdas JT. Second generation logarithmic estimates of single‐pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205–1213
  10. . Agarwal R. How can we prevent intradialytic hypotension? Curr Opin Nephrol Hypertens. 2012; 21:593–599
  11. World Medical Association Declaration of Helsinki. J Am Med Assoc 2013; 310: 20
  12. El-Sheikh M, El-Ghazaly G. Assessment of hemodialysis adequacy in patients with chronic kidney disease in the hemodialysis unit at Tanta University Hospital in Egypt. Indian J Nephrol 2016; 26(6): 398-404.
  13. Somji SS, Ruggajo P, Moledina S. Adequacy of hemodialysis and Its Associated Factors among Patients Undergoing Chronic Hemodialysis in Dares Salam, Tanzania. Int J Nephrol 2020; vol 2020: 9863065
  14. Depner T. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int.2004; 65(4): 1386-94
  15. Alebiosu CO, Ayodele OO, Abbas A, Olutoyin AI: Chronic Renal Failure at the Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria. Afr J Health Sci 2006, 6(3):132-138.
  16. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012; 59(1 Suppl 1): A7, e1-420.
  17. Soleymanian T, Kokabeh Z, Ramaghi R, Mahjoub A, Argani H Clinical outcomes and quality of life in hemodialysis diabetic patients versus non-diabetics. J Nephropathol 2017; 6(2): 81-89
  18. . Raikou VD, Kyriaki D. The Association between Intradialytic Hypertension and Metabolic Disorders in End Stage Renal Disease. Int J Hypertension 2018; Volume 2018 |Article ID 1681056 | 9 pages | https://doi.org/10.1155/2018/1681056. Accessed 16/08/2018.
  19. Meyring-Wosten, Zhang H, Kotanko A. Intradialytic hypoxaemia and clinical outcomes in patients on haemodialysis. Clin J Am Soc Nephrol (CJASN). 2017; 30: 464-72.
  20. . Teixeira NF, de Campos G, Xavier de Paula SM, Merchi VA, Portero-Mclellan KC, da Motta DG et al. Dialysis adequacy and nutritional status of haemodialyzed patients. Hemodial Int.2008; 12(1): 45-51
  21. Ghondup T, Qian Q. Electrolyte and Acid-Base disorders in Chronic Kidney Disease and End stage kidney failure. Blood Purification. 2017; 43: 179-188.
  22. Tentori F, Zhang J, Li Y, et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2012; 27(11): 4180-8
  23. Meyer TW, Sirich TL, Fong KD, Plummer NS, Shafi T, Hwang S et al Kt/V urea and non-urea small solute levels in the hemodialysis study. J Am Soc Nephrol 2016; 27: 3469–3478
  24. Amira CO, Braimoh RW, Bello BT. Pattern of intradialytic complications at the Lagos university teaching hospital. Afr J Med Med Sci. 2012; 41(4): 411–6.
  25. . McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease – a new aspect of cardiovascular disease. Blood Purif. 2010; 29((2)): 105–10.
  26. Rich A, Ellershaw J, Ahmad R. Palliative care involvement in patients stopping haemodialysis. J. Palliative Med 2001; 15: 513-514.
  27. Fernández P, Núñez S, De Arteaga J, Chiurchiu C, Douthat W, De La Fuente J. Inadequate doses of hemodialysis. Predisposing factors, causes and prevention]. Medicina (B. Aires) 2017; 77(2): 111-116
  28. Chang KY, Kim SH, Kim YO, Jin DC, Song HC, Choi EJ. The impact of blood flow rate during hemodialysis on all-cause mortality Korean J Intern Med 2016; 31(6): 1131-1139
  29. Donati G, Ursino M, Spazzoli A, Natali N, Schillaci R, Conte D et al. Sodium Prescription in the Prevention of Intradialytic Hypotension: New Insights into an Old Concept. In-depth Review. Blood purification 2018; 45: 61-70
  30. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S et al. Serum and dialysate potassium concentration and survival haemodialysis patients. Clin J Am Soc Nephrol
How to Cite
Uduagbamen, P., & Kadiri, S. (2023). Dialysis Prescription: Determinants and relationship with intradialytic complications and the dialysis dose. A prospective study. Ethiopian Medical Journal, 61(1). Retrieved from https://emjema.org/index.php/EMJ/article/view/2003

Send mail to Author

Send Cancel